医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Monoclonal gammopathy of undetermined significance (D47.200x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introductio
Monoclonal gammopathy (D47.200x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Monoclonal gammopathy (D47.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Megakaryocytic myelosclerosis (D47.103) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Myelosclerosis with myeloid metaplasia (D47.102) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Myelofibrosis with myeloid metaplasia (D47.101) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Myelodysplastic/myeloproliferative neoplasm in remission, unclassifiable (D47.100x018) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pa
Chronic myeloproliferative disease in remission, unclassifiable (D47.100x017) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathologica
Down-syndrome-associated myeloproliferative disease (D47.100x009) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introducti
Myelodysplastic/myeloproliferative neoplasm, unclassifiable (D47.100x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological in
Chronic myeloproliferative disease, unclassifiable (D47.100x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introductio
Chronic myeloproliferative neoplasm (D47.100x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being comp
Chronic myeloproliferative disease (D47.100x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Chronic myeloproliferative disease (D47.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Uncertain-/unknown-behavior histiocytic and mast-cell tumor (D47.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introd
Childhood myelodysplastic syndrome (D46.902) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Preleukemic syndrome (D46.901) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Therapy-related AML and MDS (D46.900x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Myelodysplastic syndrome (D46.900x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Myelodysplastic anemia (D46.900x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
